Alergologia Polska - Polish Journal of Allergology最新文献

{"title":"Diagnostic and treatment trends in chronic urticaria. Retrospective and prospective analysis of patients from the Department of Dermatology, Medical University of Poznan","authors":"A. Błaszczyk, D. Jenerowicz, F. Raciborski, A. Sadowska-Przytocka, Z. Adamski, M. Czarnecka-Operacz","doi":"10.5114/PJA.2021.109382","DOIUrl":"https://doi.org/10.5114/PJA.2021.109382","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"8 1","pages":"139-145"},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Rehabilitation of patients after COVID-19","authors":"Katarzyna Patlewicz, R. Pawliczak","doi":"10.5114/PJA.2021.109380","DOIUrl":"https://doi.org/10.5114/PJA.2021.109380","url":null,"abstract":"The number of patients after COVID-19 keeps growing, and many of them have to face the long-term consequences of the disease, referred to as the,post-COVID syndrome\". Due to the multitude of the symptoms alone as well as of the complications, the rehabilitation procedure must counteract those complications already taking place as well as prevent onset any future ones, so that the patient can be assured of restoration of the quality of their life the way it was before they fell ill with the disease at least. In order to develop an efficient rehabilitation model that could meet the current needs, at the same time taking into account the condition of healthcare, analyzed has been the hitherto research as well as the observations conducted, basing it all on the already systematized acquis of the rehabilitation circle.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"8 1","pages":"130-133"},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparison of two currently available anti-COVID-19 vaccines","authors":"R. Pawliczak","doi":"10.5114/PJA.2021.102554","DOIUrl":"https://doi.org/10.5114/PJA.2021.102554","url":null,"abstract":"At the end of 2020, the all-over-the-world vaccination against COVID-19 programs have been launched Currently in Poland we have two vaccines available In this short review we are trying to compare them, based on available literature data This may help physicians and patients All parties should have in mind that this data are limited by time and number of exposed, so it will be changing while the vaccinated population is growing","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"8 1","pages":"19-20"},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Recommendations of the Polish Society of Allergology on the \u0000qualification of person with allergies and anaphylaxis to vaccination against COVID-19","authors":"J. Kruszewski, E. Cichocka-Jarosz, E. Czarnobilska, M. Jutel, M. Kulus, P. Kuna, M. Kupczyk, M. Niedoszytko, M. Nittner-Marszalska, C. Pałczyński, B. Rogala, B. Samoliński, R. Spiewak, Justyna Zajdel-Całkowska","doi":"10.5114/PJA.2021.104220","DOIUrl":"https://doi.org/10.5114/PJA.2021.104220","url":null,"abstract":"Recommendations of the Polish Society of Allergology regarding the qualification of person with allergies and anaphylaxis for vaccination against COVID-19 were presented, both for doctors qualifying for vaccination against COVID-19 who are not allergologists and for allergologists consulting patients with a history of anaphylaxis or severe (uncontrolled) allergic diseases and asthma vaccinated against COVID-19","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70478884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cases of anaphylaxis after the Comirnaty© vaccine and promotion \u0000of allergy epidemic are unfavourable for the National Vaccination \u0000Programme – recommendations of the epidemiology experts-team and of the national consultant in allerglogy are unrealistic","authors":"M. Kurek","doi":"10.5114/PJA.2021.104654","DOIUrl":"https://doi.org/10.5114/PJA.2021.104654","url":null,"abstract":"No cases of anaphylaxis were registered In the clinical trials of the Pfizer-BioNTech and Moderna mRNA vaccines In December mass vaccination programs have been implemented in the United Kingdom and in the United States In the U K two anaphylactic episodes were registered after the first dose of the mRNA Pfizer vaccine which were two women with known food and drug allergies At least a dozen episodes have been reported in the USA It was also speculated that the incidence of anaphylaxis due to usage of the Pfizer vaccine, might be 10-times higher, as the incidence with all other vaccines Anaphylactic episodes related to mRNA Moderna vaccine seems to be rarer In response to the first two episodes, related to the Pfizer vaccine, the MHRA excluded any person with an history of anaphylaxis after food, drug, or vaccine In the USA, the CDC excluded any person who has a history of a severe or immediate allergic reaction associated with any of the vaccine components, such as polyethylene glycol (PEG) and other glycols We believe the reasoning behind that this is too vague and these precautions are too extreme Thy only security measure that should be applied is post vaccinal surveillance on global, national and individual level Appropriate reference points are accessible These are as follow: revised nomenclature for allergy for global use, as well, definitions and management principles of adverse drug reactions In Poland vaccination program started at the end of December On December 26, recommendations of our Epidemiology Experts-team appeared Unfortunately these are a just compilation of MHRA and CDC precautions Recommendations of the National Consultant in Allergology appeared on December 28 Instead exclusion of every person with an history of anaphylaxis after food, drug, or vaccine, a special caution is recommended after every episode It is required that an allergist detects sensi-tisations to all ingredients of the Comirnaty© vaccine In fact this is unrealistic In Poland these substances are not accessible for the routine diagnostic Unfortunately the global unified terminology for allergy and adverse drug reactions is rarely respected by academicians, and by allergists The real prevalence of clinically relevant phenomenon of individual hypersensitivity, allergic and nonallergic alike, remains unclear or misinterpreted This disturbs the doctor’ s logical reasoning and increase the patient`s fears","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Statement of Polish Respiratory Society and Polish Society of Allergology on the treatment of pulmonary complications in patients after SARS-CoV-2 infection","authors":"W. Piotrowski, A. Barczyk, A. Chciałowski, J. Chorostowska-Wynimko, M. Czajkowska-Malinowska, A. Kania, M. Kupczyk, K. Sładek, M. Kulus, P. Śliwiński","doi":"10.5114/pja.2021.109379","DOIUrl":"https://doi.org/10.5114/pja.2021.109379","url":null,"abstract":"The aim of this document is to provide physicians treating patients with a history of COVID-19 pneumonia with recommendations on proper diagnostics and management of respiratory sequelae associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The expert panel provides 32 recommendations with respect to the treatment of lung consequences (including antibiotic therapy, corticosteroid therapy, and antithrombotic prophylaxis and treatment), pulmonary rehabilitation, lung transplantation, patient monitoring, and ambulatory settings. The management of patients with respiratory comorbidities (asthma, chronic obstructive pulmonary disease, lung cancer, and interstitial lung disease) and the medications used for treatment of these conditions, such as corticosteroids and antifibrotic drugs, is discussed. Presented recommendations are based on the most recent reports and aimed at providing patients post-COVID-19 respiratory sequelae with optimal standards of care.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"8 1","pages":"101-129"},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The relationship between house dust mites \u0000and environmental factors beyond the analysis power \u0000of a skin prick test","authors":"S. Kılıç, M. M. Cicekliyurt, Sibel Oymak Yalçın","doi":"10.5114/PJA.2021.106687","DOIUrl":"https://doi.org/10.5114/PJA.2021.106687","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"8 1","pages":"64-71"},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Multisystem inflammatory syndrome in children – allergist and immunologist point of view","authors":"A. Sybilski","doi":"10.5114/pja.2021.111796","DOIUrl":"https://doi.org/10.5114/pja.2021.111796","url":null,"abstract":"Multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) is a complication following SARS-CoV-2 infection. It may appear a few weeks after coronavirus infection, even if it was asymptomatic. Symptoms may appear gradually in the following days of illness and may be mild to severe in its course. The most common symptoms of MIS-C include fever > 3 days, gastrointestinal symptoms, skin changes. Shock can often occur. The key pathomechanism of the syndrome is hyperinflammation and an altered cytokine profile. Activation of T lymphocytes in MIS-C is mediated by the superantigen, which is the spike protein of the virus. The clinical picture and the immune pathophysiological profile show similarities between MIS-C and Kawasaki diseases (KD). The relationship of MIS-C with allergic diseases has not been investigated, but by analogy it can be assumed that it will be similar to KD. Allergic rhinitis, asthma, and atopic dermatitis have been demonstrated to increase following KD. Children who have previously suffered from combined allergic diseases (atopic dermatitis, allergic rhinitis, and urticaria) are at an increased risk of developing KD. There is an increased risk of KD in children who had sought medical care for allergic diseases more than twice a year compared to children with fewer medical visits. Data on the relationship of KD with atopy indicate the need to undertake studies analyzing MIS-C in this context.","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A new dimension of the lipid transfer protein syndrome – attention to sex, drugs and alcohol","authors":"K. Buczyłko","doi":"10.5114/pja.2021.111797","DOIUrl":"https://doi.org/10.5114/pja.2021.111797","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Isolated allergic conjunctivitis","authors":"E. Mrukwa-Kominek, Julia Janiszewska-Salamon, Agnieszka Urgacz-Lechowicz, Wojciech Luboń, R. Gawlik","doi":"10.5114/pja.2021.106684","DOIUrl":"https://doi.org/10.5114/pja.2021.106684","url":null,"abstract":"","PeriodicalId":7469,"journal":{"name":"Alergologia Polska - Polish Journal of Allergology","volume":"1 1","pages":""},"PeriodicalIF":0.2,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70479089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}